High PD‐L1 level of advanced hepatic lymphoepithelioma‐like carcinoma response favorably to lenvatinib plus toripalimab

Lymphoepithelioma‐like carcinoma (LELC) is an uncommon subtype of primary liver cancer with predominant lymphocyte infiltration and a relatively favorable outcome. However, no standard treatment for advanced hepatic LELC has been established. Here, we give a first report of a 60‐year‐old man with ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yueting, Dang, Zhuyi, Xu, Hang, Yuan, Yunlong, Chen, Ye, Li, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128174/
https://www.ncbi.nlm.nih.gov/pubmed/35298067
http://dx.doi.org/10.1111/cas.15339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128174/
https://www.ncbi.nlm.nih.gov/pubmed/35298067
http://dx.doi.org/10.1111/cas.15339

Ejemplares similares